Related Experiment Video
Updated: Aug 8, 2026

Static Adhesion Assay for the Study of Integrin Activation in T Lymphocytes
Published on: June 13, 2014
Characterization of ICAM-2 and evidence for a third counter-receptor for LFA-1
A R de Fougerolles1, S A Stacker, R Schwarting
1Department of Pathology, Harvard Medical School, Boston, Massachusetts 02115.
Insights
Researchers developed monoclonal antibodies to characterize human intercellular adhesion molecule-2 (ICAM-2). They found ICAM-2 is expressed on lymphocytes and endothelium, and plays a role in cell adhesion, though a third LFA-1 ligand may exist.
Area of Science:
- Immunology
- Cell Biology
- Molecular Biology
Background:
- Human intercellular adhesion molecule-2 (ICAM-2) is a cell surface glycoprotein involved in cell adhesion.
- Understanding ICAM-2's role is crucial for characterizing immune responses and inflammatory processes.
Purpose of the Study:
- To further characterize human ICAM-2 using newly developed monoclonal antibodies.
- To investigate the expression patterns and functional roles of ICAM-2 in cell adhesion and immune cell interactions.
Main Methods:
- Generation of murine monoclonal antibodies (mAbs) against ICAM-2 transfected cells.
- Immunoprecipitation and SDS-PAGE to determine ICAM-2 molecular weight.
- N-glycanase treatment to identify the peptide backbone.
- Flow cytometry and tissue staining to assess ICAM-2 expression.
- Cell binding assays and homotypic aggregation assays to evaluate ICAM-2 function in lymphocyte function-associated antigen-1 (LFA-1) mediated adhesion.
Main Results:
- Two mAbs, CBR-IC2/1 and CBR-IC2/2, were generated.
- ICAM-2 has a molecular weight of approximately 60,000, with a peptide backbone of 31,000.
- ICAM-2 is broadly expressed on hematopoietic cell lines and cultured endothelial cells, with expression on resting lymphocytes and monocytes but not neutrophils.
- ICAM-2 is highly expressed on vascular endothelium.
- Unlike ICAM-1, ICAM-2 expression shows little induction upon inflammatory stimulation.
- mAb CBR-IC2/2 inhibited ICAM-2 binding to LFA-1, indicating ICAM-2 is an LFA-1 ligand.
- ICAM-1 and ICAM-2 together account for LFA-1-dependent binding to endothelium.
- Homotypic aggregation of JY cells is dependent on ICAM-1 and ICAM-2.
- A third LFA-1 ligand, distinct from ICAM-1 and ICAM-2, was identified on SKW3 cells.
Conclusions:
- ICAM-2 is a significant adhesion molecule expressed on endothelium and certain immune cells.
- ICAM-2, along with ICAM-1, mediates LFA-1-dependent cell adhesion.
- The study suggests the existence of an additional LFA-1 ligand, highlighting complexity in cell adhesion pathways.
Abstract:
In an endeavor to further characterize human intercellular adhesion molecule-2 (ICAM-2), two murine monoclonal antibodies (mAb) were generated to ICAM-2 transfected COS cells, and designated CBR-IC2/1 and CBR-IC2/2. Immunoprecipitated, reduced ICAM-2 migrated as a broad band of Mr 60,000 in sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Treatment with N-glycanase revealed a peptide backbone of Mr 31,000, consistent with the size predicted from the cDNA. ICAM-2 had a broad distribution on hematopoietic cell lines and little expression on other cell lines, the sole exception being cultured endothelial cells which possess high levels of ICAM-2. Resting lymphocytes and monocytes expressed ICAM-2, while neutrophils did not. Staining of tissue sections with anti-ICAM-2 mAb confirmed their strong reactivity to vascular endothelium, but demonstrated a lack of ICAM-2 expression on other tissues. Small clusters of ICAM-2 positive cells were, however, seen in germinal centers. In contrast to ICAM-1 there was little or no induction of ICAM-2 expression on lymphocytes or cultured endothelium upon stimulation with inflammatory mediators. One of the two mAb, CBR-IC2/2, was found to totally inhibit binding of ICAM-2+ COS cells to purified lymphocyte function-associated antigen-1 (LFA-1). Using this mAb, LFA-1-dependent binding to both stimulated and unstimulated endothelium was found to be totally accounted for by ICAM-1 and ICAM-2. Homotypic aggregation of an Epstein-Barr virus-transformed B cell line, JY, was found to be solely ICAM-1 and ICAM-2-dependent, while in the case of the T cell lymphoma cell line, SKW3, anti- ICAM-2 mAb in conjunction with anti-ICAM-1 mAb could not inhibit the LFA-1-dependent aggregation. This suggests an additional LFA-1 ligand exists. Using a cell binding assay to purified LFA-1 in conjunction with anti-ICAM-1 and anti-ICAM-2 mAb, we have demonstrated that this putative third ligand for LFA-1 exists on SKW3 and other cell lines.
Related Concept Videos
Receptor-mediated Endocytosis
Intracellular Signaling Affects Focal Adhesions
Some...
Adherens Junctions
Adherens Junctions are Dynamic
The endothelial cells...
Immunoglobulin-like Cell Adhesion Molecules
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...

